Ivan Milenković

3.0k total citations
49 papers, 1.6k citations indexed

About

Ivan Milenković is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ivan Milenković has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 16 papers in Molecular Biology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ivan Milenković's work include Alzheimer's disease research and treatments (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Ivan Milenković is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Parkinson's Disease Mechanisms and Treatments (8 papers). Ivan Milenković collaborates with scholars based in Austria, Germany and Netherlands. Ivan Milenković's co-authors include Gábor G. Kovács, Eleonora Aronica, Homa Adle‐Biassette, Mirjam I. Lutz, Werner Sieghart, Herbert Budka, Romana Höftberger, Günther Regelsberger, Harald Heinzl and Ellen Gelpí and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Neuron.

In The Last Decade

Ivan Milenković

48 papers receiving 1.6k citations

Peers

Ivan Milenković

PHYSI

CMN

NEURO

Desheng Xu China

Helen Y. Figueroa United States

Kazuhiro Niizato Japan

Christopher M. Henstridge United Kingdom

Pascal Dournaud France

Pamela J. McMillan United States

Thomas Debeir France

Thomas G. Beach Canada

Fu‐Lei Tang United States

David Virley United Kingdom

Desheng Xu China

Ivan Milenković

812 ×1.4

328 ×0.6

PHYSI

915 ×1.9

CMN

217 ×0.6

NEURO

288 ×1.0

NEURO

Citations per year, relative to Ivan Milenković Ivan Milenković (= 1×) peers Desheng Xu

Countries citing papers authored by Ivan Milenković

Since Specialization

Citations

This map shows the geographic impact of Ivan Milenković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Milenković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Milenković more than expected).

Fields of papers citing papers by Ivan Milenković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Milenković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Milenković. The network helps show where Ivan Milenković may publish in the future.

Co-authorship network of co-authors of Ivan Milenković

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Milenković. A scholar is included among the top collaborators of Ivan Milenković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Milenković. Ivan Milenković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krenn, Martin, Matias Wagner, Karin Trimmel, et al.. (2025). Holistic Exome-Based Genetic Testing in Adults With Epilepsy. Neurology Genetics. 11(3). e200260–e200260. 1 indexed citations

Milenković, Ivan, Inbal Biton, Mirie Zerbib, et al.. (2024). Efficacy of an AAV vector encoding a thermostable form of glucocerebrosidase in alleviating symptoms in a Gaucher disease mouse model. Gene Therapy. 31(9-10). 439–444. 1 indexed citations

Shalit, Tali, et al.. (2023). Proteomics analysis of the brain from a Gaucher disease mouse identifies pathological pathways including a possible role for transglutaminase 1. Journal of Neurochemistry. 168(1). 52–65.

Krenn, Martin, et al.. (2022). A de novo truncating variant in CSDE1 in an adult-onset neuropsychiatric phenotype without intellectual disability. European Journal of Medical Genetics. 65(3). 104423–104423. 3 indexed citations

Milenković, Ivan, Gregor Kasprian, & Gerald Wiest. (2021). Saccadic Hypermetria From a Selective Lesion of the Fastigial Oculomotor Region. Neurology. 96(9). 449–451. 1 indexed citations

Milenković, Ivan, et al.. (2021). GBA mutations, glucosylceramide and Parkinson's disease. Current Opinion in Neurobiology. 72. 148–154. 26 indexed citations

Milenković, Ivan, Lucie Bartova, K. Papageorgiou, et al.. (2021). Case Report: Bupropion Reduces the [123I]FP-CIT Binding to Striatal Dopamine Transporter. Frontiers in Psychiatry. 12. 631357–631357. 1 indexed citations

Kasugai, Yu, Heide Hörtnagl, Enrica Paradiso, et al.. (2019). Structural and Functional Remodeling of Amygdala GABAergic Synapses in Associative Fear Learning. Neuron. 104(4). 781–794.e4. 25 indexed citations

Milenković, Ivan, et al.. (2018). A novel nonsense autosomal dominant mutation in the GLRA1 gene causing hyperekplexia. Journal of Neural Transmission. 125(12). 1877–1883. 3 indexed citations

10.

Rohan, Zdeněk, Ivan Milenković, Mirjam I. Lutz, Radoslav Matěj, & Gábor G. Kovács. (2016). Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies. Journal of Neuropathology & Experimental Neurology. 75(12). 1100–1109. 36 indexed citations

11.

Rahimi, Jasmin, Ivan Milenković, & Gábor G. Kovács. (2015). Patterns of Tau and α-Synuclein Pathology in the Visual System. Journal of Parkinson s Disease. 5(2). 333–340. 16 indexed citations

12.

Alpár, Alán, Giuseppe Tortoriello, Daniela Calvigioni, et al.. (2014). Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nature Communications. 5(1). 4421–4421. 56 indexed citations

13.

Iyer, Anand M., Jackelien van Scheppingen, Ivan Milenković, et al.. (2014). Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes. Current Alzheimer Research. 11(7). 694–705. 30 indexed citations

14.

Iyer, Anand M., Jackelien van Scheppingen, Ivan Milenković, et al.. (2014). mTOR Hyperactivation in Down Syndrome Hippocampus Appears Early During Development. Journal of Neuropathology & Experimental Neurology. 73(7). 671–683. 57 indexed citations

15.

Iyer, Anand M., Jackelien van Scheppingen, Jasper J. Anink, et al.. (2013). Developmental patterns of DR6 in normal human hippocampus and in Down syndrome. Journal of Neurodevelopmental Disorders. 5(1). 10–10. 10 indexed citations

16.

Sarto‐Jackson, Isabella, Ivan Milenković, Karl‐Heinz Smalla, et al.. (2012). The Cell Adhesion Molecule Neuroplastin-65 Is a Novel Interaction Partner of γ-Aminobutyric Acid Type A Receptors. Journal of Biological Chemistry. 287(17). 14201–14214. 39 indexed citations

17.

Maj, Magdalena, Ivan Milenković, Jan Bauer, et al.. (2012). Novel Insights into the Distribution and Functional Aspects of the Calcium Binding Protein Secretagogin from Studies on Rat Brain and Primary Neuronal Cell Culture. Frontiers in Molecular Neuroscience. 5. 84–84. 22 indexed citations

18.

Tretter, Verena, Ivan Milenković, Sarah Ramsden, et al.. (2011). Molecular Basis of the γ-Aminobutyric Acid A Receptor α3 Subunit Interaction with the Clustering Protein Gephyrin. Journal of Biological Chemistry. 286(43). 37702–37711. 87 indexed citations

19.

Heisler, Frank F., Torben J. Hausrat, Susanne Fehr, et al.. (2011). Spatio-temporal expression analysis of the calcium-binding protein calumenin in the rodent brain. Neuroscience. 202. 29–41. 16 indexed citations

20.

Preusser, Matthias, Harald Heinzl, Ellen Gelpí, et al.. (2008). Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology. 53(1). 39–47. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact